Academia
While Boston tends to get the lion’s share of recognition as the premier biopharma hub on the East Coast of the United States, other cities and states are looking to make their names known as a strong location for the industry.
It is well-known that women are more likely to get Alzheimer’s disease than men, but exactly why hasn’t been clearly understood. Research presented at the Alzheimer’s Association International Conference (AAIC) in Los Angeles today describes several genes linked to the disease only in men and others related to risk only in women.
For quite some time, the focus of the cause of Alzheimer’s disease was on beta-amyloid, a protein that accumulates in the brains of individuals with the disease and which appears to cause at least some of the damage that results in memory and cognition issues. There are other candidates, and research appears to be heating up on the role of inflammation.
Multiple sclerosis (MS) is an often-disabling disease of the central nervous system caused by damage to the myelin coating around the nerves.
When a group of our neurons get activated by thinking hard about a math problem or the vibrant colors of an exotic flower, within a single second blood flow to those brain cells increases a bit.
How can you selectively target and destroy cancerous T-cells using other T-cells? This question has plagued researches hoping to apply chimeric antigen receptor (CAR) T-cell therapies to T-cell cancers.
One of the big topics presented at the Alzheimer’s Association International Conference (AAIC) 2019 in Los Angeles was the effect of lifestyle on the risk of Alzheimer’s disease.
It was a typically busy week for clinical trials, with announcements in a wide variety of indications. Here’s a look.
Researchers last year identified a gene, mEAK-7, that now appears to play a significant role in how lung cancer metastasizes.
Research Team Combines Multi-Spectral Imaging and Supercomputing
PRESS RELEASES